AN2 Therapeutics

AN2 Therapeutics

Innovative small molecule therapeutics targeting infectious diseases and oncology using boron chemistry.

HQ location
Menlo Park, United States
Launch date
Employees
Market cap
$31.2m
Enterprise value
($32m)
Share price
$1.10 ANTX
Authorizing premium user...